Literature DB >> 27848218

Evaluation of diagnostic and prognostic significance of Ki-67 index in pulmonary carcinoid tumours.

V Clay1,2, G Papaxoinis1, B Sanderson1, J W Valle1,2, M Howell1, A Lamarca1, P Krysiak3, P Bishop4, D Nonaka2,5, W Mansoor6,7.   

Abstract

BACKGROUND: Pulmonary carcinoid (PC) tumours are classified as either typical (TC) or atypical (AC) according to mitotic index (MI) and presence of necrosis. The aim of this study was to analyse the diagnostic and prognostic values of the Ki-67 index in PC. METHODS/PATIENTS: Between January 2001 and March 2015, we evaluated 94 consecutive patients with a confirmed diagnosis of TC (n = 75) or AC (n = 19) at our institution. Diagnostic histology was centrally reviewed by a local expert neuroendocrine pathologist, with assessment of Ki-67, MI, and necrosis.
RESULTS: Median patient follow-up was 35 months. Eighty-four patients who underwent curative surgical resection were included in the survival analysis for identification of prognostic factors. Ki-67 index showed high diagnostic accuracy to predict histological subtype when assessed by receiver operator characteristic curves with an area under the curve of 0.923 (95% CI 0.852-0.995, p < 0.001). Multivariate analysis showed that MI, Ki-67 index, and the presence or absence of necrosis were independent prognostic factors for relapse-free survival. Combination of MI, Ki-67, and necrosis led to the classification of patients into four different prognostic groups (very low, low, intermediate, and high risks of relapse).
CONCLUSIONS: The current study proposes the incorporation of Ki-67 index in the prognostic classification of PC tumours. Due to the limited number of patients and length of follow-up, the current model needs validation by larger cohort studies. Nevertheless, our results suggest that Ki-67 index and MI have continuous effect on prognosis. Prognostic models incorporating multiple cutoffs of Ki-67 and MI might better predict outcome and inform clinical decisions.

Entities:  

Keywords:  Atypical; Ki-67; Neuroendocrine tumours; Prognosis; Pulmonary carcinoids; Typical

Mesh:

Substances:

Year:  2016        PMID: 27848218     DOI: 10.1007/s12094-016-1568-z

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  21 in total

Review 1.  Neuroendocrine tumors of the lung: an update.

Authors:  Natasha Rekhtman
Journal:  Arch Pathol Lab Med       Date:  2010-11       Impact factor: 5.534

2.  Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach.

Authors:  Tina Zahel; Sabine Krysa; Esther Herpel; Albrecht Stenzinger; Benjamin Goeppert; Peter Schirmacher; Hans Hoffmann; Philipp A Schnabel; Arne Warth
Journal:  Virchows Arch       Date:  2012-03       Impact factor: 4.064

Review 3.  Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature.

Authors:  G Fink; T Krelbaum; A Yellin; D Bendayan; M Saute; M Glazer; M R Kramer
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

4.  TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study.

Authors:  G Rindi; M Falconi; C Klersy; L Albarello; L Boninsegna; M W Buchler; C Capella; M Caplin; A Couvelard; C Doglioni; G Delle Fave; L Fischer; G Fusai; W W de Herder; H Jann; P Komminoth; R R de Krijger; S La Rosa; T V Luong; U Pape; A Perren; P Ruszniewski; A Scarpa; A Schmitt; E Solcia; B Wiedenmann
Journal:  J Natl Cancer Inst       Date:  2012-04-23       Impact factor: 13.506

5.  Survival analysis of 200 pulmonary neuroendocrine tumors with clarification of criteria for atypical carcinoid and its separation from typical carcinoid.

Authors:  W D Travis; W Rush; D B Flieder; R Falk; M V Fleming; A A Gal; M N Koss
Journal:  Am J Surg Pathol       Date:  1998-08       Impact factor: 6.394

Review 6.  Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.

Authors:  Giuseppe Pelosi; Guido Rindi; William D Travis; Mauro Papotti
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

7.  Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Authors:  G Rindi; C Klersy; F Inzani; G Fellegara; L Ampollini; A Ardizzoni; N Campanini; P Carbognani; T M De Pas; D Galetta; P L Granone; L Righi; M Rusca; L Spaggiari; M Tiseo; G Viale; M Volante; M Papotti; G Pelosi
Journal:  Endocr Relat Cancer       Date:  2013-12-16       Impact factor: 5.678

8.  ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival.

Authors:  Birgit Guldhammer Skov; Bente Holm; Anders Erreboe; Torsten Skov; Anders Mellemgaard
Journal:  J Thorac Oncol       Date:  2010-04       Impact factor: 15.609

9.  Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score.

Authors:  Franco Grimaldi; Daniele Muser; Carlo Alberto Beltrami; Piernicola Machin; Angelo Morelli; Stefano Pizzolitto; Giovanni Talmassons; Francesca Marciello; Annamaria Anita Livia Colao; Roberto Monaco; Guglielmo Monaco; Antongiulio Faggiano
Journal:  Front Endocrinol (Lausanne)       Date:  2011-08-19       Impact factor: 5.555

10.  TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system.

Authors:  G Rindi; G Klöppel; H Alhman; M Caplin; A Couvelard; W W de Herder; B Erikssson; A Falchetti; M Falconi; P Komminoth; M Körner; J M Lopes; A-M McNicol; O Nilsson; A Perren; A Scarpa; J-Y Scoazec; B Wiedenmann
Journal:  Virchows Arch       Date:  2006-09-12       Impact factor: 4.064

View more
  10 in total

1.  Diagnostic and prognostic value of CT perfusion parameters in patients with advanced NSCLC after chemotherapy.

Authors:  Guangyao Lin; Yuan Sui; Yiming Li; Wenqi Huang
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 2.  Classification of pulmonary neuroendocrine tumors: new insights.

Authors:  Giuseppe Pelosi; Angelica Sonzogni; Sergio Harari; Adriana Albini; Enrica Bresaola; Caterina Marchiò; Federica Massa; Luisella Righi; Gaia Gatti; Nikolaos Papanikolaou; Namrata Vijayvergia; Fiorella Calabrese; Mauro Papotti
Journal:  Transl Lung Cancer Res       Date:  2017-10

3.  Long-term outcomes and prognostic factors of patients with surgically treated pulmonary atypical carcinoid tumors: our institutional experience with 68 patients.

Authors:  Peng Song; Ruochuan Zang; Lei Liu; Xiayimaier Dan; Shugeng Gao
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

4.  Proteasome inhibitor bortezomib enhances the effect of standard chemotherapy in small cell lung cancer.

Authors:  Sanaz Taromi; Florentine Lewens; Ruza Arsenic; Dagmar Sedding; Jörg Sänger; Almut Kunze; Markus Möbs; Joana Benecke; Helma Freitag; Friederike Christen; Daniel Kaemmerer; Amelie Lupp; Mareike Heilmann; Hedwig Lammert; Claus-Peter Schneider; Karen Richter; Michael Hummel; Britta Siegmund; Meike Burger; Franziska Briest; Patricia Grabowski
Journal:  Oncotarget       Date:  2017-09-23

5.  Relationship between the Ki67 index and its area based approximation in breast cancer.

Authors:  Muhammad Khalid Khan Niazi; Caglar Senaras; Michael Pennell; Vidya Arole; Gary Tozbikian; Metin N Gurcan
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

Review 6.  Follow-Up Recommendations after Curative Resection of Well-Differentiated Neuroendocrine Tumours: Review of Current Evidence and Clinical Practice.

Authors:  Angela Lamarca; Hamish Clouston; Jorge Barriuso; Mairéad G McNamara; Melissa Frizziero; Was Mansoor; Richard A Hubner; Prakash Manoharan; Sarah O'Dwyer; Juan W Valle
Journal:  J Clin Med       Date:  2019-10-05       Impact factor: 4.241

Review 7.  Lung neuroendocrine neoplasms: recent progress and persistent challenges.

Authors:  Natasha Rekhtman
Journal:  Mod Pathol       Date:  2021-10-18       Impact factor: 7.842

8.  Prognostic nomogram for predicting long-term survival in bronchopulmonary carcinoid tumor patients receiving resection.

Authors:  Qiao Li; Qichen Chen; Jinghua Chen; Zijing Wang; Pan Wang; Hong Zhao; Jun Zhao
Journal:  Ann Transl Med       Date:  2021-09

9.  Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis.

Authors:  Salma Naheed; Chloe Holden; Lulu Tanno; Linda Pattini; Neil W Pearce; Bryan Green; Eleanor Jaynes; Judith Cave; Christian H Ottensmeier; Giuseppe Pelosi
Journal:  BMJ Open       Date:  2022-03-03       Impact factor: 2.692

10.  Clinic and genetic similarity assessments of atypical carcinoid, neuroendocrine neoplasm with atypical carcinoid morphology and elevated mitotic count and large cell neuroendocrine carcinoma.

Authors:  Ying Zhang; Weiya Wang; Zuoyu Liang; Ping Zhou; Yuan Tang; Lili Jiang; Qianrong Hu
Journal:  BMC Cancer       Date:  2022-03-24       Impact factor: 4.430

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.